In MTC, we found 14 GPCR DEGs, including an upregulation of the dopamine receptor (DRD2) and adenosine receptor (ADORA2B), which were the target of many drugs. The gene discussed is ADORA2B; the disease is medullary thyroid gland carcinoma.